DE1294953B - Das Monocarbamat des 2, 3-Dimethyl-2-n-propyl-3-p-chlorphenyl-1, 3-propandiols und Verfahren zu seiner Herstellung - Google Patents
Das Monocarbamat des 2, 3-Dimethyl-2-n-propyl-3-p-chlorphenyl-1, 3-propandiols und Verfahren zu seiner HerstellungInfo
- Publication number
- DE1294953B DE1294953B DE1965R0042156 DER0042156A DE1294953B DE 1294953 B DE1294953 B DE 1294953B DE 1965R0042156 DE1965R0042156 DE 1965R0042156 DE R0042156 A DER0042156 A DE R0042156A DE 1294953 B DE1294953 B DE 1294953B
- Authority
- DE
- Germany
- Prior art keywords
- propyl
- methyl
- propanediol
- chlorophenyl
- dimethyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- KNXFNHQNBPBCMT-UHFFFAOYSA-N 3-(4-chlorophenyl)-2-methyl-2-propylbutane-1,3-diol Chemical compound CC(CO)(C(O)(C1=CC=C(C=C1)Cl)C)CCC KNXFNHQNBPBCMT-UHFFFAOYSA-N 0.000 title claims description 6
- 238000000034 method Methods 0.000 title claims description 6
- 238000002360 preparation method Methods 0.000 title claims description 5
- -1 methyl zinc halide Chemical class 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 7
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 claims description 6
- JVZZUPJFERSVRN-UHFFFAOYSA-N 2-methyl-2-propylpropane-1,3-diol Chemical compound CCCC(C)(CO)CO JVZZUPJFERSVRN-UHFFFAOYSA-N 0.000 claims description 4
- 239000003795 chemical substances by application Substances 0.000 claims description 4
- METJRNPZJAUAGA-UHFFFAOYSA-N 2-(hydroxymethyl)-2-methylpentanoic acid Chemical compound CCCC(C)(CO)C(O)=O METJRNPZJAUAGA-UHFFFAOYSA-N 0.000 claims description 3
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 claims description 3
- YGYAWVDWMABLBF-UHFFFAOYSA-N Phosgene Chemical compound ClC(Cl)=O YGYAWVDWMABLBF-UHFFFAOYSA-N 0.000 claims description 3
- 150000008044 alkali metal hydroxides Chemical class 0.000 claims description 3
- 229910021529 ammonia Inorganic materials 0.000 claims description 3
- 125000004432 carbon atom Chemical group C* 0.000 claims description 3
- 150000001732 carboxylic acid derivatives Chemical class 0.000 claims description 3
- 239000012320 chlorinating reagent Substances 0.000 claims description 3
- 239000007800 oxidant agent Substances 0.000 claims description 3
- 150000003855 acyl compounds Chemical class 0.000 claims description 2
- 238000001640 fractional crystallisation Methods 0.000 claims description 2
- ULWHHBHJGPPBCO-UHFFFAOYSA-N propane-1,1-diol Chemical compound CCC(O)O ULWHHBHJGPPBCO-UHFFFAOYSA-N 0.000 claims 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 24
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 15
- 239000000243 solution Substances 0.000 description 15
- 125000002252 acyl group Chemical group 0.000 description 8
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- 238000004821 distillation Methods 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 239000010410 layer Substances 0.000 description 5
- 239000003826 tablet Substances 0.000 description 5
- 229940125725 tranquilizer Drugs 0.000 description 5
- 239000003204 tranquilizing agent Substances 0.000 description 5
- 230000002936 tranquilizing effect Effects 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 229920000166 polytrimethylene carbonate Polymers 0.000 description 4
- 238000003756 stirring Methods 0.000 description 4
- YPFDHNVEDLHUCE-UHFFFAOYSA-N 1,3-propanediol Substances OCCCO YPFDHNVEDLHUCE-UHFFFAOYSA-N 0.000 description 3
- 229940035437 1,3-propanediol Drugs 0.000 description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 125000003668 acetyloxy group Chemical group [H]C([H])([H])C(=O)O[*] 0.000 description 3
- 150000002009 diols Chemical class 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- OZVKHKCTYYNAES-UHFFFAOYSA-N 2-(acetyloxymethyl)-2-methylpentanoic acid Chemical compound CCCC(C)(C(O)=O)COC(C)=O OZVKHKCTYYNAES-UHFFFAOYSA-N 0.000 description 2
- 206010002091 Anaesthesia Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- WETWJCDKMRHUPV-UHFFFAOYSA-N acetyl chloride Chemical compound CC(Cl)=O WETWJCDKMRHUPV-UHFFFAOYSA-N 0.000 description 2
- 239000012346 acetyl chloride Substances 0.000 description 2
- 230000037005 anaesthesia Effects 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 230000003001 depressive effect Effects 0.000 description 2
- 239000006196 drop Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- 230000000144 pharmacologic effect Effects 0.000 description 2
- 239000012286 potassium permanganate Substances 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 239000000829 suppository Substances 0.000 description 2
- 239000000725 suspension Substances 0.000 description 2
- 239000006188 syrup Substances 0.000 description 2
- 235000020357 syrup Nutrition 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- NZUGGMISMNJLGR-UHFFFAOYSA-N 3-(hydroxymethyl)-3-methylhexan-2-one Chemical compound CC(C(C)=O)(CO)CCC NZUGGMISMNJLGR-UHFFFAOYSA-N 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- RMBLRPRCSHCTGV-UHFFFAOYSA-N ClC=1C=CC2=C(C=[N+](CC=N2)[O-])C=1 Chemical compound ClC=1C=CC2=C(C=[N+](CC=N2)[O-])C=1 RMBLRPRCSHCTGV-UHFFFAOYSA-N 0.000 description 1
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 1
- 239000001828 Gelatine Substances 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- 206010043268 Tension Diseases 0.000 description 1
- OMOVVBIIQSXZSZ-UHFFFAOYSA-N [6-(4-acetyloxy-5,9a-dimethyl-2,7-dioxo-4,5a,6,9-tetrahydro-3h-pyrano[3,4-b]oxepin-5-yl)-5-formyloxy-3-(furan-3-yl)-3a-methyl-7-methylidene-1a,2,3,4,5,6-hexahydroindeno[1,7a-b]oxiren-4-yl] 2-hydroxy-3-methylpentanoate Chemical compound CC12C(OC(=O)C(O)C(C)CC)C(OC=O)C(C3(C)C(CC(=O)OC4(C)COC(=O)CC43)OC(C)=O)C(=C)C32OC3CC1C=1C=COC=1 OMOVVBIIQSXZSZ-UHFFFAOYSA-N 0.000 description 1
- OOULTEVOQWLHLN-UHFFFAOYSA-M [Cl-].[Cd+]C Chemical group [Cl-].[Cd+]C OOULTEVOQWLHLN-UHFFFAOYSA-M 0.000 description 1
- SDCPWDJNIYMMKJ-UHFFFAOYSA-M [I-].C[Cd+] Chemical compound [I-].C[Cd+] SDCPWDJNIYMMKJ-UHFFFAOYSA-M 0.000 description 1
- IWAMTNPLBGULMY-UHFFFAOYSA-M [I-].[Zn+]C Chemical group [I-].[Zn+]C IWAMTNPLBGULMY-UHFFFAOYSA-M 0.000 description 1
- 150000008065 acid anhydrides Chemical class 0.000 description 1
- 229910001854 alkali hydroxide Inorganic materials 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical class N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 150000008064 anhydrides Chemical class 0.000 description 1
- 229940125717 barbiturate Drugs 0.000 description 1
- 239000002585 base Substances 0.000 description 1
- 238000009835 boiling Methods 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000012043 crude product Substances 0.000 description 1
- 239000008298 dragée Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 150000004820 halides Chemical class 0.000 description 1
- IXCSERBJSXMMFS-UHFFFAOYSA-N hydrogen chloride Substances Cl.Cl IXCSERBJSXMMFS-UHFFFAOYSA-N 0.000 description 1
- 229910000041 hydrogen chloride Inorganic materials 0.000 description 1
- 238000007912 intraperitoneal administration Methods 0.000 description 1
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- VXWPONVCMVLXBW-UHFFFAOYSA-M magnesium;carbanide;iodide Chemical compound [CH3-].[Mg+2].[I-] VXWPONVCMVLXBW-UHFFFAOYSA-M 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- QXLPXWSKPNOQLE-UHFFFAOYSA-N methylpentynol Chemical compound CCC(C)(O)C#C QXLPXWSKPNOQLE-UHFFFAOYSA-N 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- UHZYTMXLRWXGPK-UHFFFAOYSA-N phosphorus pentachloride Chemical compound ClP(Cl)(Cl)(Cl)Cl UHZYTMXLRWXGPK-UHFFFAOYSA-N 0.000 description 1
- FAIAAWCVCHQXDN-UHFFFAOYSA-N phosphorus trichloride Chemical compound ClP(Cl)Cl FAIAAWCVCHQXDN-UHFFFAOYSA-N 0.000 description 1
- 230000003389 potentiating effect Effects 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000010992 reflux Methods 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical compound ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- NMLXKNNXODLJIN-UHFFFAOYSA-M zinc;carbanide;chloride Chemical compound [CH3-].[Zn+]Cl NMLXKNNXODLJIN-UHFFFAOYSA-M 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C45/00—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
- C07C45/61—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups
- C07C45/67—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton
- C07C45/673—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton
- C07C45/676—Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds by reactions not involving the formation of >C = O groups by isomerisation; by change of size of the carbon skeleton by change of size of the carbon skeleton by elimination of carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/16—Preparation of carboxylic acids or their salts, halides or anhydrides by oxidation
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR999590A FR4475M (https=) | 1964-12-22 | 1964-12-22 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE1294953B true DE1294953B (de) | 1969-05-14 |
Family
ID=8845349
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE1965R0042156 Pending DE1294953B (de) | 1964-12-22 | 1965-12-07 | Das Monocarbamat des 2, 3-Dimethyl-2-n-propyl-3-p-chlorphenyl-1, 3-propandiols und Verfahren zu seiner Herstellung |
Country Status (6)
| Country | Link |
|---|---|
| BE (1) | BE673250A (https=) |
| CH (1) | CH448990A (https=) |
| DE (1) | DE1294953B (https=) |
| FR (1) | FR4475M (https=) |
| GB (1) | GB1068650A (https=) |
| NL (1) | NL145848B (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4546203A (en) * | 1981-12-11 | 1985-10-08 | American Hoechst Corporation | Facile synthesis of β-hydroxy-β-methylglutaric acid |
| DK496682A (da) * | 1981-12-11 | 1983-06-12 | Hoechst Co American | Fremgangsmaade til fremstilling af beta-hydroxy-beta-methylglutarsyre |
| US6900270B2 (en) | 2002-10-31 | 2005-05-31 | Basf Corporation | Curable coating compositions with carbamate compounds |
| US6977309B2 (en) * | 2002-10-31 | 2005-12-20 | Basf Corporation | Compounds having a secondary or tertiary hydroxy of halide group separated from a primary carbamate group by three or more carbon atoms and a method of making the same |
| US6858674B2 (en) * | 2002-10-31 | 2005-02-22 | Basf Corporation | Carbamate functional materials, a method of making said materials, and curable coating compositions containing said materials |
| US6890994B2 (en) | 2002-10-31 | 2005-05-10 | Basf Corporation | Curable coating compositions with carbamate-containing acrylic polymers |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1063146B (de) * | 1957-08-16 | 1959-08-13 | Hoffmann La Roche | Verfahren zur Herstellung von Carbaminsaeureestern |
-
1964
- 1964-12-22 FR FR999590A patent/FR4475M/fr not_active Expired
-
1965
- 1965-12-03 BE BE673250D patent/BE673250A/xx unknown
- 1965-12-07 DE DE1965R0042156 patent/DE1294953B/de active Pending
- 1965-12-07 NL NL656515912A patent/NL145848B/xx unknown
- 1965-12-21 CH CH1756265A patent/CH448990A/fr unknown
- 1965-12-22 GB GB54300/65A patent/GB1068650A/en not_active Expired
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1063146B (de) * | 1957-08-16 | 1959-08-13 | Hoffmann La Roche | Verfahren zur Herstellung von Carbaminsaeureestern |
Also Published As
| Publication number | Publication date |
|---|---|
| GB1068650A (en) | 1967-05-10 |
| FR4475M (https=) | 1966-10-03 |
| BE673250A (https=) | 1966-06-03 |
| NL145848B (nl) | 1975-05-15 |
| CH448990A (fr) | 1967-12-31 |
| NL6515912A (https=) | 1966-06-23 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE2810253C2 (https=) | ||
| CH641432A5 (de) | Verfahren zur aufspaltung von racemischer 6-methoxy-alpha-methyl-2-naphthalinessigsaeure in die optischen antipoden. | |
| DE1134086B (de) | Verfahren zur Herstellung von analeptisch wirksamen alpha-Aminoisobutyrophenonen und deren Säureadditionssalzen | |
| DE1804691C3 (de) | Taurocholensäurederivate | |
| DE1294953B (de) | Das Monocarbamat des 2, 3-Dimethyl-2-n-propyl-3-p-chlorphenyl-1, 3-propandiols und Verfahren zu seiner Herstellung | |
| DE1493797B2 (de) | Verfahren zur Herstellung von neuen substituierten Malonsäuremonohydraziden | |
| DE1493618A1 (de) | Cumarinderivate und ein Verfahren zu ihrer Herstellung | |
| DE2721261C3 (de) | Verfahren zur Herstellung von Din-propylacetamid | |
| DE2843040C2 (https=) | ||
| AT211821B (de) | Verfahren zur Herstellung Alkylaminoacetaryliden | |
| DE2143720C3 (de) | Verfahren zur Herstellung von reinem DL-Tryptophan | |
| DE2155857A1 (de) | Neue chemische Verbindungen und Verfahren zu ihrer Herstellung | |
| AT228189B (de) | Verfahren zur Herstellung des neuen γ-Lactons der 2,3-Dihydroxycyclododecen-(1)-carbonsäure und seiner Salze mit Alkalimetallen | |
| DE481733C (de) | Verfahren zur Darstellung von C, C-disubstituierten Derivaten der Barbitursaeure | |
| DE679972C (de) | Verfahren zur Reinherstellung von Di-(p-phenetyl)-(2-aethoxypyridyl-5)-guanidin | |
| DE2200589C3 (de) | Nicotinoylglycin-ß-pyridylmethylester | |
| DE943946C (de) | Verfahren zur Trennung von DL-threo-1-p-Nitrophenyl-2-amino-1, 3-propandiol in seineoptisch aktiven Antipoden | |
| DE606615C (de) | Verfahren zur Herstellung von Tetrazolabkoemmlingen der Terpenreihe | |
| DE1900948C (de) | Cis- und trans-2-Methyl-5-(3, 4, S-trimethoxybenzamidoJ-decahydroisochinolin | |
| AT216495B (de) | Verfahren zur Herstellung von neuen Phenylalaninderivaten und deren Salzen | |
| AT203482B (de) | Verfahren zur Darstellung von neuen N-Alkyl-p-toluolsulfonylaminoessigsäuren | |
| AT269835B (de) | Verfahren zur Herstellung von neuen basischen, tricyclischen Verbindungen und deren Salzen | |
| AT234676B (de) | Verfahren zur Herstellung von 7-Methoxy-1,2,3,4,4a,9,10,10a-octahydrophenanthrenverbindungen, welche in 2-Stellung die Carbamylgruppe oder eine substituierte Carbamylgruppe aufweisen | |
| DE2402231B2 (de) | Verfahren zur herstellung von 4- acetamidophenyl-2-acetoxybenzoat | |
| DE1167849B (de) | Verfahren zur Herstellung von N'-Isopropyl-N-acylhydraziden |